Potential benefits of purified long chain omega-3 fatty acid treatment in non-alcoholic fatty liver disease (NAFLD): a potential treatment for early NAFLD in metabolic syndrome and... מאת Scorletti, E, Bhatia, B, McCormick, K, Clough, G, Nash, K, Hodson, L, Calder, P, Byrne, C

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study. מאת Scorletti, E, Bhatia, L, McCormick, K, Clough, G, Nash, K, Hodson, L, Moyses, H, Calder, P, Byrne, C